EMILY HARRINGTON

Graduate student, Molecular Pharmacology and Chemical Biology, University of Pittsburgh’s School of Medicine


Emily is a graduate student with a B.S. in Molecular Biology/Biochemistry and a Mathematics Minor from Penn State Behrend in Erie, Pennsylvania. Her current project involves understanding the role of endocrine therapy resistance in invasive lobular breast cancer (ILC), in order to find new therapies for patients afflicted by ILC.


Email:

eah71@pitt.edu
harringtonea2@upmc.edu

LinkedIn:
https://www.linkedin.com/in/emily-bossart-7683a222